ROTE WILLIAM E. (Senior Vice President, R&D) sold 2.3% of their position (2.76K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $121.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/7/2026ACC: 0001698262-26-000004
Officer· Senior Vice President, R&D
Since Nov 2018
+5.74K
Net shares
Net buyer
$121.4K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
12.75K acquired · 7.01K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.25K
Price / share
—
Trade value
—
% of position
3.7%
5/4/2026
113.99K→118.24K
Common Stock
Direct
Shares
−2.76K
Price / share
$43.95
Trade value
$121.43K
% of position
2.3%
5/6/2026
118.24K→115.47K
Total
Net shares
+1.49K
Net value
-$121.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | M · Option Exercise | +4.25K | — | — | 3.7% | 113.99K | 118.24K |
| Common Stock Direct | 5/6/2026 | S · Sale | −2.76K | $43.95 | $121.43K | 2.3% | 118.24K | 115.47K |
| Total | +1.49K | -$121.43K | ||||||
Derivative Transactions2
Performance-based restricted stock units
Direct
Converts to
Common Stock
8.50K shares
Shares
+8.50K
Strike price
Held after
8.50K
Exercisable
—
5/4/2026
Performance-based restricted stock units
Direct
Converts to
Common Stock
4.25K shares
Shares
−4.25K
Strike price
Held after
4.25K
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-based restricted stock units Direct | Common Stock8.50K shares | 5/4/2026 | A · Award | +8.50K | — | 8.50K | |
| Performance-based restricted stock units Direct | Common Stock4.25K shares | 5/4/2026 | M · Option Exercise | −4.25K | — | 4.25K |